3P Biopharmaceuticals has a 68% female workforce with a scientific background

by 3PBIOVIAN

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products has a 68% female wor...

Read more

BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1

by 3PBIOVIAN

3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegene...

Read more

3P Biopharmaceuticals entre las 100 mejores empresas para trabajar en España

by 3PBIOVIAN

3P Biopharmaceuticals (3P), organización líder especializada en el desarrollo de procesos cGMP y fabricación de productos biológicos (CDMO) ha sido seleccionada como una de las 100 mejores empresa...

Read more

3P Biopharmaceuticals appoints Kenneth McMahon as Head of Quality Control

by 3PBIOVIAN

3P Biopharmaceuticals (3P), a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO) appoints a new member as head of quality control.

Read more

3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra

by 3PBIOVIAN

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the...

Read more

3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA

by 3PBIOVIAN

The investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total flo...

Read more

3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain

by 3PBIOVIAN

3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.

Read more

3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology

by 3PBIOVIAN

3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to...

Read more

3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours

by 3PBIOVIAN

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.

Read more

3P Biopharmaceuticals y Buzzard Pharmaceuticals inician una colaboración para desarrollar un nuevo tratamiento oncológico

by 3PBIOVIAN

3P se ocupará de la fabricación cGMP de Isunakinra, un medicamento contra tumores sólidos, que se encuentra en fase I/II de desarrollo en pacientes en EEUU

Read more

La esperanza de reducir las complicaciones cardiovasculares asociadas a la diálisis

by 3PBIOVIAN

Las empresas biotecnológicas Invizius y 3P Biopharmaceuticals colaboran en una tecnología innovadora para los pacientes que se someten a hemodiálisis y sufren de enfermedades cardiovasculares

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

OneChain’s CAR-T therapy OC-1 shows en...

by OneChain Immunotherapeutics

New preliminary data presented at EHA 2026 highlight the potential of ...

Photos Stream